Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01499732 · ClinicalTrials.gov registry record

Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects

A clinical trial of Healthy and Rheumatoid Arthritis, sponsored by Orrin M Troum, M.D. and Medical Associates.

Completed
Registry status
15
Enrollment target
1
Study location

NCT01499732 is a study of Healthy and Rheumatoid Arthritis that has completed, run by Orrin M Troum, M.D. and Medical Associates. The registered enrollment target is 15 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01499732, a study of Healthy and Rheumatoid Arthritis, has completed, sponsored by Orrin M Troum, M.D. and Medical Associates.

COMPLETED
Registry status
15 participants
Enrollment target
1
Study location

Study Summary

Premature Endothelial Dysfunction is present in patients with early rheumatoid arthritis.

Study Locations (1)

California

  • Orrin M. Troum, MD and Medical Associates - Santa Monica

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2011-12
Est. Completion 2012-11

What the Registry Record Tells You About NCT01499732

The ClinicalTrials.gov registry entry for NCT01499732 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Orrin M Troum, M.D. and Medical Associates, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT01499732 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01499732 about?

NCT01499732 is a clinical study titled "Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects". Premature Endothelial Dysfunction is present in patients with early rheumatoid arthritis.

What is the current status of trial NCT01499732?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2011-12. Estimated completion is 2012-11.

What conditions does trial NCT01499732 study?

This clinical trial studies the following conditions: Healthy, Rheumatoid Arthritis, Premature Endothelial Dysfunction.

Who is sponsoring clinical trial NCT01499732?

This trial is sponsored by Orrin M Troum, M.D. and Medical Associates, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01499732 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.